Authors
Loading...
Population pharmacokinetic modeling demonstrates predictable intracellular tacrolimus exposure in kidney transplant recipients, suggesting routine blood monitoring suffices.
Udomkarnjananun et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: